Toward targeted treatments for silicosis

Area of Science:

• Pulmonary Medicine
• Toxicology
• Pharmacology

Background:

• Silicosis cases are increasing, particularly linked to artificial stone products.
• Current management focuses on silica exposure avoidance, yet progressive disease develops without standard treatments.

Approach:

• This review summarizes existing literature on pharmacological therapies for silicosis.
• It examines the potential efficacy of these treatments based on disease pathogenesis.

Key Points:

• In-vitro and in-vivo studies suggest drugs targeting inflammasomes, cytokines, effector cells, fibrosis, autophagy, and oxidation may be effective.
• Limited human studies exist, highlighting a gap in clinical translation.

Conclusions:

• Potential therapeutic targets for silicosis are emerging from preclinical research.
• Effective treatment likely requires a multimodal approach addressing inflammation, fibrosis, autophagy, and reactive oxygen species (ROS).